The project MIRIA aims to develop wide-range-antimicrobial nanocoatings to be used in hospitals and other environments where cross-contamination and contagion risk are significant issues. MIRIA main challenging ambition is to develop nanocoatings with a 99.99% effectiveness against a wide range of pathogens, especially SARS-CoV-2. This will be based on a four pieces puzzle: the knowledge in anti-microbial materials, nanopowders, nanocoating and pilot plant conduction. These nanocoatings will be brought to pilot scale (TRL6) and, within 3 years after the end of the project, they are foreseen to enter the market (TRL9). The exploitation of MIRIA outputs deeply involves SMEs and the dissemination plan will follow a spill-over strategy in order to involve public and private stakeholders.
Company Details
- Founded
- -
- Address
- Rome, It
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://miriaproject.eu
- HQ
- Rome
Miria Eu Project Questions
Miria Eu Project's website is https://miriaproject.eu
Miria Eu Project's LinkedIn profile is https://it.linkedin.com/company/miria-eu-project
Miria Eu Project's industry is
Research Services
Miria Eu Project's top competitors are
Protec Surface Technologies S.r.l,
Alvo Medical,
Gwm Group,
Stabilized Electrical Steels For Electric Mobility Project (Steels-Em),
Lab4green Srl,
Prodinger & Partner St. Johann Steuerberatung Gmbh,
Miria Group,
Systerion,
Smartweld,
Stop: Surface Transfer Of Pathogens.
Miria Eu Project's categories are Research Services
Miria Eu Project's founding year is 2022
